Association among mortality, risk factors and polymorphisms related to immune dysfunction (NISE study; Nagoya immune system in ESRD study)

Association among mortality, risk factors and polymorphisms related to immune dysfunction (NISE study; Nagoya immune system in ESRD study) - NISE study

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000000680

Enrollment

300

Registered

2007-04-17

Start date

2007-04-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic kidney disease (including end-stage renal disease)

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1)chronic kidney disease a)patients with end-stage renal disease shortly after initiation of renal replacement therapy 2)fully informed consent should be obtained

Exclusion criteria

Exclusion criteria: 1)over 75 years old of age 2)acute infectious disease when entry of this study 3)severe liver dysfunction

Design outcomes

Primary

Measure	Time frame
mortality including all-cause, cardiovascular and infectious deaths, onset of cardiovascular event and infection	—

Secondary

Measure	Time frame
Atherosclerosis (ankle-brachial index and pulse wave velocity), malnutrition, chronic inflammation	—

Countries

Japan,Europe

Contacts

Public ContactSawako Kato

Nagoya University Nephrology

kato07@med.nagoya-u.ac.jp052-744-2192

Outcome results